22 October 2025 | ICC Sydney

MedTech Conference Program

The MedTech Conference is shaping up to be the most dynamic program on the MedTech calendar, covering key areas in reimbursement, regulatory, industry growth, clinical trials, and much more.

The Program is subject to changes.

Registration Open

Join the premier event for MedTech Professionals

Register Now

Wednesday, 22 October 2025

Day 1
Day 2

8:45am - 8:55am

Plenary

Short intro by Conference MC

Warren Bingham is a prominent figure in the medical devices, biotechnology and digital health sectors, known for his leadership and innovative contributions. He is the Founder and Executive Chairman of MedTech International, Global Vice President of ARIA Research, Executive Chairman of OmnisOva, Chairman of Agscent, and MTAA Board member. With over 30 years of experience in the medical devices sector, Warren specializes in guiding organizations towards innovation and success, particularly in medical devices and biotechnologies, excelling in global strategic execution, commercialization, and board fulfillment. In addition to his professional endeavors, Warren is deeply committed to philanthropy and community engagement. He serves as an Ambassador for the Vinnies CEO Sleepout and Diabetes Australia, contributes as a member of the Springboard Enterprises LifeSciences Council, and coaches for the Cerebral Palsy Alliance’s Accelerator, Remarkable and Taronga HATCH accelerator. Warren actively participates in initiatives aimed at driving positive change and making a tangible difference in people’s lives. Among Warren’s notable contributions to the healthcare industry is his role in establishing the Australian subsidiary of Given Imaging Ltd in 2001. Under his leadership, Given Imaging pioneered PillCam® technology, revolutionizing the visualization of the GI tract with its ingestible pill-sized camera. Warren’s strategic initiatives also led to the successful inclusion of Capsule Endoscopy on Australia’s Medicare Benefits Scheme in 2004. During his tenure on the global management team from 2000, Given Imaging experienced exponential growth, evolving from a start-up to a multinational, publicly traded company with revenues surpassing $250 million by 2013. In February 2014, Covidien acquired Given Imaging for approximately $1 billion. Warren’s exceptional leadership and contributions have garnered widespread recognition over the years. He was a finalist in the 2016 Australian Institute of Management’s ‘Excellence in Leadership Awards’ and was acknowledged by AusBiotech in 2018 for his ‘Outstanding Contribution to AusMedtech’. In 2019, Warren was named an Adjunct Fellow at Macquarie University and received the prestigious Medical Technology Association of Australia (MTAA) Outstanding Achievement Award in 2021 for his remarkable contributions to industry development, patient outcomes, and leadership. Warren’s unwavering passion, dedication, and visionary leadership continue to inspire positive change, drive innovation, and leave a lasting impact on the world

Official Welcome to Country

8.55am -9.05am

Plenary

Session 1 - Welcome and Official Opening

9.05am-9.55am

Plenary

Session 2 - Ministerial Address

10.00am-10.45am

Plenary

A presentation of the key findings and recommendations of the Digital Health Reimbursement review and recommendations followed by a panel discussion.

10.45am-11.15am

Morning tea in the Expo

11.20am-12.20pm

Plenary

Melanie is a recognised leader in design, technology, and social innovation, named one of the Top 100 Women of Influence by The Australian Financial Review. She leads transformative initiatives at Nous Group and is pursuing a PhD focused on improving emergency care experiences for young people through human-centred design. A sought-after speaker and award-winning changemaker, Melanie has presented on global stages including Google’s APAC UX Design Summit, TEDxSydney, and the Vogue Codes Summit.

Melanie is a recognised leader in design, technology, and social innovation, named one of the Top 100 Women of Influence by The Australian Financial Review. She leads transformative initiatives at Nous Group and is pursuing a PhD focused on improving emergency care experiences for young people through human-centred design. A sought-after speaker and award-winning changemaker, Melanie has presented on global stages including Google’s APAC UX Design Summit, TEDxSydney, and the Vogue Codes Summit.

12.25pm-1.10pm

Plenary

Join TGA’s Tracey Duffy and MTAA’s Ian Burgess as they reflect on Australia’s regulatory reform agenda, share key insights from the recent Regulatory Summit, and explore how industry can build capability.

1.10pm-2.10pm

Lunch in the Expo

2.10pm-2.40pm

Plenary

2.10pm-3.10pm

Concurrent

2.40pm-3.10pm

Plenary

3.10pm-3.30pm

Afternoon tea in the Expo

3.30pm-4.20pm

Plenary

3.40pm-4.20pm

Concurrent

4.20pm-5.20pm

Plenary

The Investor Hypothetical challenges the way we think about how MedTech start-ups are funded, scaled, and exited. The session walks through the life cycle of a MedTech company, from idea to public listing or trade sale, using live pitches, real funding milestones, and mock investor scenarios.

Designed as an interactive alternative to traditional panels, the goal is to unpack the real-world decisions — and dilemmas — that founders, investors, and advisors face at each stage: from MVP to raising capital, navigating term sheets, and preparing for exit. We want to demystify what makes a venture ‘investable’, highlight the tensions between innovation and investor risk appetite, and examine whether our current system sets Australian companies up for long-term success — or offshore exit.

Participants will include start-ups, incubators, angel and venture capital investors, strategic acquirers, and public market experts from Australia and the Asia-Pacific region. It will be high-energy, interactive, and designed to spark candid insights into what it takes to fund and scale successful MedTech ventures.

5.20pm-5.25pm

Plenary

Closing Remarks and invite to Welcome Reception

Warren Bingham is a prominent figure in the medical devices, biotechnology and digital health sectors, known for his leadership and innovative contributions. He is the Founder and Executive Chairman of MedTech International, Global Vice President of ARIA Research, Executive Chairman of OmnisOva, Chairman of Agscent, and MTAA Board member. With over 30 years of experience in the medical devices sector, Warren specializes in guiding organizations towards innovation and success, particularly in medical devices and biotechnologies, excelling in global strategic execution, commercialization, and board fulfillment. In addition to his professional endeavors, Warren is deeply committed to philanthropy and community engagement. He serves as an Ambassador for the Vinnies CEO Sleepout and Diabetes Australia, contributes as a member of the Springboard Enterprises LifeSciences Council, and coaches for the Cerebral Palsy Alliance’s Accelerator, Remarkable and Taronga HATCH accelerator. Warren actively participates in initiatives aimed at driving positive change and making a tangible difference in people’s lives. Among Warren’s notable contributions to the healthcare industry is his role in establishing the Australian subsidiary of Given Imaging Ltd in 2001. Under his leadership, Given Imaging pioneered PillCam® technology, revolutionizing the visualization of the GI tract with its ingestible pill-sized camera. Warren’s strategic initiatives also led to the successful inclusion of Capsule Endoscopy on Australia’s Medicare Benefits Scheme in 2004. During his tenure on the global management team from 2000, Given Imaging experienced exponential growth, evolving from a start-up to a multinational, publicly traded company with revenues surpassing $250 million by 2013. In February 2014, Covidien acquired Given Imaging for approximately $1 billion. Warren’s exceptional leadership and contributions have garnered widespread recognition over the years. He was a finalist in the 2016 Australian Institute of Management’s ‘Excellence in Leadership Awards’ and was acknowledged by AusBiotech in 2018 for his ‘Outstanding Contribution to AusMedtech’. In 2019, Warren was named an Adjunct Fellow at Macquarie University and received the prestigious Medical Technology Association of Australia (MTAA) Outstanding Achievement Award in 2021 for his remarkable contributions to industry development, patient outcomes, and leadership. Warren’s unwavering passion, dedication, and visionary leadership continue to inspire positive change, drive innovation, and leave a lasting impact on the world

5.30pm-7.30pm

Plenary

Welcome Reception | Pre-dinner drinks

5:30pm-7:30pm

5:30pm-7:30pm

7.15pm-7.30pm

Welcome Reception | Pre-dinner drinks

Acoustic Duo featuring Justine Eltakchi

Industry Award Finalists Announcement

7.30pm-11.00pm

Industry Awards Dinner

Tickets Now Available

22 October 2025

Register

Support your Colleagues and Industry Peers

Attending the MTAA MedTech Industry Awards offers unparalleled opportunities for professionals to connect with industry leaders, celebrate groundbreaking innovations, and gain visibility within Australia’s dynamic medical technology sector.

The MTAA MedTech Industry Awards dinner at ICC Sydney serves as a platform to recognise excellence, inspiring attendees to push boundaries in their own work.

Tickets Now Available

22 October 2025

Register

Become a sponsor of MedTech Industry Awards

MTAA has a variety of sponsorship packages available. Visit the Sponsorship page to learn more.

View Sponsorship

Thursday, 23 October 2025

Day 1
Day 2

8.00am

Registration opens | Coffee Cart Open

8.30am-8.40am

Plenary

Welcome back (Include Acknowledgement of Country)

Warren Bingham is a prominent figure in the medical devices, biotechnology and digital health sectors, known for his leadership and innovative contributions. He is the Founder and Executive Chairman of MedTech International, Global Vice President of ARIA Research, Executive Chairman of OmnisOva, Chairman of Agscent, and MTAA Board member. With over 30 years of experience in the medical devices sector, Warren specializes in guiding organizations towards innovation and success, particularly in medical devices and biotechnologies, excelling in global strategic execution, commercialization, and board fulfillment. In addition to his professional endeavors, Warren is deeply committed to philanthropy and community engagement. He serves as an Ambassador for the Vinnies CEO Sleepout and Diabetes Australia, contributes as a member of the Springboard Enterprises LifeSciences Council, and coaches for the Cerebral Palsy Alliance’s Accelerator, Remarkable and Taronga HATCH accelerator. Warren actively participates in initiatives aimed at driving positive change and making a tangible difference in people’s lives. Among Warren’s notable contributions to the healthcare industry is his role in establishing the Australian subsidiary of Given Imaging Ltd in 2001. Under his leadership, Given Imaging pioneered PillCam® technology, revolutionizing the visualization of the GI tract with its ingestible pill-sized camera. Warren’s strategic initiatives also led to the successful inclusion of Capsule Endoscopy on Australia’s Medicare Benefits Scheme in 2004. During his tenure on the global management team from 2000, Given Imaging experienced exponential growth, evolving from a start-up to a multinational, publicly traded company with revenues surpassing $250 million by 2013. In February 2014, Covidien acquired Given Imaging for approximately $1 billion. Warren’s exceptional leadership and contributions have garnered widespread recognition over the years. He was a finalist in the 2016 Australian Institute of Management’s ‘Excellence in Leadership Awards’ and was acknowledged by AusBiotech in 2018 for his ‘Outstanding Contribution to AusMedtech’. In 2019, Warren was named an Adjunct Fellow at Macquarie University and received the prestigious Medical Technology Association of Australia (MTAA) Outstanding Achievement Award in 2021 for his remarkable contributions to industry development, patient outcomes, and leadership. Warren’s unwavering passion, dedication, and visionary leadership continue to inspire positive change, drive innovation, and leave a lasting impact on the world

8.40am-9.25am

Plenary

Women’s health has long been underrepresented in research, innovation, and healthcare delivery creating a Women’s Health Gap. But momentum is building, with new policies, funding, and innovation reshaping the landscape both here in Australia and across the globe. This session explores what women’s health really means, why it matters, and where the MedTech sector has a unique opportunity to lead change.

9.25am-9.35am

Plenary

The current edition of the Medical Technology Industry Code of Practice – Edition 13 – is being updated to ensure it remains fit-for-purpose and consistent with the relevant laws and regulations in Australia. This session will provide an overview of the planned changes and outline the next steps.

9.40am-10.40am

Plenary

As innovation in medical technology accelerates, health systems around the world face growing pressure to make timely, evidence-based decisions about access and reimbursement. Yet traditional health technology assessment (HTA) frameworks often struggle to keep pace – particularly in their ability to incorporate real-world data (RWD) and real-world evidence (RWE).

This session will explore how smarter, more adaptive approaches to evidence generation and evaluation can unlock faster, fairer access to medical technologies. Through a series of short presentations and a panel discussion, MedTech leaders will examine:
– The current barriers to RWE adoption in HTA and payer decision-making.
– Emerging frameworks that expand the definition of value to include social and system-level outcomes.
– Real-world examples of how clinical registry data and collaborative evidence models have supported successful reimbursement decisions in Australia (and beyond).

Attendees will gain practical insights into what both policymakers and industry can do to align on evidence expectations, build trust in evolving data sources, and together create a future-ready HTA ecosystem that delivers better outcomes for Australian patients.

Warren Bingham is a prominent figure in the medical devices, biotechnology and digital health sectors, known for his leadership and innovative contributions. He is the Founder and Executive Chairman of MedTech International, Global Vice President of ARIA Research, Executive Chairman of OmnisOva, Chairman of Agscent, and MTAA Board member. With over 30 years of experience in the medical devices sector, Warren specializes in guiding organizations towards innovation and success, particularly in medical devices and biotechnologies, excelling in global strategic execution, commercialization, and board fulfillment. In addition to his professional endeavors, Warren is deeply committed to philanthropy and community engagement. He serves as an Ambassador for the Vinnies CEO Sleepout and Diabetes Australia, contributes as a member of the Springboard Enterprises LifeSciences Council, and coaches for the Cerebral Palsy Alliance’s Accelerator, Remarkable and Taronga HATCH accelerator. Warren actively participates in initiatives aimed at driving positive change and making a tangible difference in people’s lives. Among Warren’s notable contributions to the healthcare industry is his role in establishing the Australian subsidiary of Given Imaging Ltd in 2001. Under his leadership, Given Imaging pioneered PillCam® technology, revolutionizing the visualization of the GI tract with its ingestible pill-sized camera. Warren’s strategic initiatives also led to the successful inclusion of Capsule Endoscopy on Australia’s Medicare Benefits Scheme in 2004. During his tenure on the global management team from 2000, Given Imaging experienced exponential growth, evolving from a start-up to a multinational, publicly traded company with revenues surpassing $250 million by 2013. In February 2014, Covidien acquired Given Imaging for approximately $1 billion. Warren’s exceptional leadership and contributions have garnered widespread recognition over the years. He was a finalist in the 2016 Australian Institute of Management’s ‘Excellence in Leadership Awards’ and was acknowledged by AusBiotech in 2018 for his ‘Outstanding Contribution to AusMedtech’. In 2019, Warren was named an Adjunct Fellow at Macquarie University and received the prestigious Medical Technology Association of Australia (MTAA) Outstanding Achievement Award in 2021 for his remarkable contributions to industry development, patient outcomes, and leadership. Warren’s unwavering passion, dedication, and visionary leadership continue to inspire positive change, drive innovation, and leave a lasting impact on the world

10.40am-11.00am

Morning tea in the Expo

11.00am-11.45am

Plenary

Within the world of digital health technologies, the number of portable and digital wearables are growing exponentially however most if not all of these technologies require the use of their own specific and proprietary digital Apps. Has anyone stopped to think about the User requirements and how a single GP or medical specialist is meant to be able to access their patient data without having to download thousands of Apps? Abbott Diagnostics are a global provider of CGM, Continuous Global Monitoring technologies for people living with Diabetes. Vidya from Nethealth has recognised this problem and developed a technology that is now being implemented in the Australian healthcare system. Prof Brinkworth from Diabetes Australia is responsible for research funded by Diabetes Australia, a patient member association with more than 300,000 members. This panel discussion will identify the speed of technology becoming available, the challenge of how to manage these if you’re a clinician and the benefits of when industry, research and innovation collaborate.

11.45am-11.55am

Plenary

11.55am-12.05pm

Plenary

Join this engaging session to explore the power of mentoring. Learn how mentoring can accelerate professional growth, foster meaningful connections, and deliver lasting, impactful outcomes for individuals, organisations, and the MedTech industry as a whole.

12.10pm-12.55pm

Plenary

In an increasingly competitive MedTech landscape, the ability to attract, retain, and support top talent has never been more critical. This session explores strategies to build high-performing teams by aligning talent acquisition with organisational purpose and culture, and by fostering environments that prioritise workforce resilience and mental wellbeing. Industry leaders and workforce experts will discuss how to future-proof your organisation through employee engagement, psychological safety, and proactive mental fitness programs that drive retention and performance.

12.00pm-12.45pm

Concurrent

12.55pm-1.40pm

Lunch in the Expo

1.40pm-2.25pm

Plenary

This session aims to raise awareness amongst MedTech suppliers regarding the evolving landscape of modern slavery regulation in NSW, particularly its implications for healthcare. It will highlight the human impact of modern slavery, the evolving regulations to address modern slavery in healthcare and provide guidance on how suppliers engage meaningfully with public entities in addressing these issues.

2.25pm-2.35pm

Plenary

2.40pm-3.25pm

Plenary

This session will explore how Australia’s healthcare sector is responding to climate change through strategic policy initiatives under the National Health and Climate Strategy.

3.25pm-3.55pm

Afternoon tea in the Expo

3.55pm-4.55pm

Plenary

The current reform work by the Department of Health, Ageing and Disability to address private hospital viability is significant for the future of private healthcare and may significantly impact coverage of medical devices. This session will follow the expected release by the Department of proposals to improve private hospital viability and stakeholder responses to these. MTAA has invited the Department to give a short overview of the key issues to be addressed, proposals being considered and next steps in the process of government deliberation. This will be followed by a discussion with panelists including representatives from hospitals, insurers, clinicians and industry of the relative pros and cons of the proposals under consideration and what this might mean for medical device access and purchasing.

3.55pm-4.55pm

Concurrent

4.55pm-5.05pm

Plenary

Closing remarks and Invitation to Closing Reception

Warren Bingham is a prominent figure in the medical devices, biotechnology and digital health sectors, known for his leadership and innovative contributions. He is the Founder and Executive Chairman of MedTech International, Global Vice President of ARIA Research, Executive Chairman of OmnisOva, Chairman of Agscent, and MTAA Board member. With over 30 years of experience in the medical devices sector, Warren specializes in guiding organizations towards innovation and success, particularly in medical devices and biotechnologies, excelling in global strategic execution, commercialization, and board fulfillment. In addition to his professional endeavors, Warren is deeply committed to philanthropy and community engagement. He serves as an Ambassador for the Vinnies CEO Sleepout and Diabetes Australia, contributes as a member of the Springboard Enterprises LifeSciences Council, and coaches for the Cerebral Palsy Alliance’s Accelerator, Remarkable and Taronga HATCH accelerator. Warren actively participates in initiatives aimed at driving positive change and making a tangible difference in people’s lives. Among Warren’s notable contributions to the healthcare industry is his role in establishing the Australian subsidiary of Given Imaging Ltd in 2001. Under his leadership, Given Imaging pioneered PillCam® technology, revolutionizing the visualization of the GI tract with its ingestible pill-sized camera. Warren’s strategic initiatives also led to the successful inclusion of Capsule Endoscopy on Australia’s Medicare Benefits Scheme in 2004. During his tenure on the global management team from 2000, Given Imaging experienced exponential growth, evolving from a start-up to a multinational, publicly traded company with revenues surpassing $250 million by 2013. In February 2014, Covidien acquired Given Imaging for approximately $1 billion. Warren’s exceptional leadership and contributions have garnered widespread recognition over the years. He was a finalist in the 2016 Australian Institute of Management’s ‘Excellence in Leadership Awards’ and was acknowledged by AusBiotech in 2018 for his ‘Outstanding Contribution to AusMedtech’. In 2019, Warren was named an Adjunct Fellow at Macquarie University and received the prestigious Medical Technology Association of Australia (MTAA) Outstanding Achievement Award in 2021 for his remarkable contributions to industry development, patient outcomes, and leadership. Warren’s unwavering passion, dedication, and visionary leadership continue to inspire positive change, drive innovation, and leave a lasting impact on the world

 

5.05pm-6.30pm

Closing reception

Contact MTAA

We respect your privacy

Sponsorship Enquiry

We respect your privacy. No contact information is shared.

Enquiry Area

We respect your privacy. No contact information is shared.

Quick links: enquire and learn more about sponsorship

Sponsorship Enquiry

If you selected exhibitor booth, please tick your preferred booth numbers.
We respect your privacy. No contact information is shared.

Thank you for your enquiry.